← All stocks

KYNTRA BIO, INC.

KYNB Net buying
CIK 0000921299 #4913 in the set updated 18 Sep 2026
Bought (12 mo)
$53.60K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$53.60K
+$53.60K against sales at will

By person

5 insiders · 3 transactions
0.2×

Thane Wettig holds only 0.2 times base salary in stock. $190.27K of shares against $665.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Thane Wettig last reported holding, valued at $7.09, the price Common Stock was last bought or sold at on the open market here, on 14 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Wettig Thane
CEO
$53.60K (3)
+$53.60K
26,836
$190.27K
Chung Christine
SVP, CHINA OPERATIONS
294,903
$2.09M
−3.1%
Graham Juan
CHIEF FINANCIAL OFFICER
164,863
$1.17M
−1.5%
Schoeneck James A
Director
39,666
$281.23K
DeLucia David
Chief Financial Officer
4,355
$30.88K
−37.5%

No percentages here. This company's share count has moved by a factor of 25.0 over the window, from 4,043,899 to 101,043,970 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Wettig Thane
14 May 2026
CEO
Buy
2,800
$7.09
$19.85K
Wettig Thane
17 Nov 2025
CEO
Buy
2,700
$9.10
$24.57K
Wettig Thane
13 Nov 2025
CEO
Buy
1,000
$9.18
$9.18K

What was left out

Form 4 filings counted 16
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,129
History held since 2 Sep 2016